Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 81.02B | -16.38%115.07B | 36.48%137.61B | 181.94%100.83B | -41.60%35.76B | -6.48%61.24B | -26.14%65.48B | 30.24%88.66B | 22.37%68.07B | -5.36%55.63B |
Net profit before non-cash adjustment | --18.5B | 19.10%114.03B | 8.20%95.75B | 39.83%88.49B | 44.29%63.28B | -29.58%43.86B | 9.65%62.29B | -11.16%56.81B | 37.32%63.94B | 1.85%46.57B |
Total adjustment of non-cash items | ---4.82B | -16.71%45.98B | 398.38%55.21B | -12.18%11.08B | -58.47%12.61B | -27.68%30.37B | 24.87%42B | 637.87%33.63B | -82.29%4.56B | -1.92%25.74B |
-Depreciation and amortization | --13.96B | 12.92%51.88B | 14.93%45.94B | 10.43%39.97B | 11.99%36.19B | 4.57%32.32B | 2.50%30.91B | 2.40%30.15B | -0.94%29.45B | -11.58%29.72B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | --963M | ---- | --2.24B | ---- | 380.85%1.36B | -90.04%282M |
-Assets reserve and write-off | ---- | 55.21%-1.07B | 72.55%-2.39B | -156.28%-8.71B | 25,696.67%15.48B | --60M | ---- | ---- | ---- | ---- |
-Disposal profit | ---250M | 31.40%-6.21B | 4.99%-9.05B | 75.93%-9.53B | -17,457.02%-39.57B | -8.43%228M | 132.85%249M | 95.81%-758M | -838.38%-18.09B | -25.85%-1.93B |
-Net exchange gains and losses | ---207M | 9.70%-428M | -109.73%-474M | -210.78%-226M | 36.91%204M | 108.08%149M | -348.72%-1.84B | 1,498.11%741M | -983.33%-53M | -99.02%6M |
-Other non-cash items | ---18.32B | -91.43%1.82B | 303.13%21.18B | -1,499.54%-10.43B | 72.67%-652M | -122.85%-2.39B | 198.48%10.44B | 143.20%3.5B | -246.07%-8.1B | 47.20%-2.34B |
Changes in working capital | --67.34B | -236.74%-44.95B | -1,154.27%-13.35B | 103.15%1.27B | -208.84%-40.14B | 66.51%-13B | -2,078.72%-38.8B | -313.23%-1.78B | 97.42%-431M | -26.46%-16.68B |
-Change in receivables | --78.29B | -25.51%-35.7B | -3,697.60%-28.44B | 96.41%-749M | -271.95%-20.85B | 155.25%12.13B | -31.96%-21.95B | -17.91%-16.63B | 37.60%-14.11B | -161.50%-22.61B |
-Change in inventory | ---17.23B | 16.92%-21.36B | -350.48%-25.71B | -175.96%-5.71B | 163.28%7.51B | 55.92%-11.87B | -288.53%-26.94B | -545.28%-6.93B | 119.93%1.56B | 37.87%-7.81B |
-Change in payables | ---18.52B | -87.75%3.52B | 1,194.59%28.71B | 83.48%-2.62B | -4.76%-15.88B | -222.15%-15.16B | -33.44%12.41B | 160.08%18.65B | -42.71%7.17B | 266.95%12.51B |
-Provision for loans, leases and other losses | ---83M | 80.70%4.24B | 133.30%2.35B | -20.66%1.01B | 260.23%1.27B | -56.11%352M | 331.12%802M | -946.34%-347M | 107.78%41M | -180.21%-527M |
-Changes in other current assets | --24.88B | -55.30%4.36B | 4.38%9.75B | 176.64%9.34B | -882.59%-12.19B | 149.76%1.56B | -189.73%-3.13B | -28.97%3.49B | 180.51%4.91B | -55.79%1.75B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -768M | -8.52%-2.17B | -14.84%-2B | -22.74%-1.74B | -1.43%-1.42B | 1.13%-1.4B | 14.53%-1.41B | 25.92%-1.65B | -2.01%-2.23B | 13.80%-2.19B |
Interest received (cash flow from operating activities) | 1.15B | -6.55%3.44B | 29.22%3.68B | -3.79%2.85B | 4.56%2.96B | -9.93%2.83B | 25.33%3.14B | -11.66%2.51B | -6.49%2.84B | 18.00%3.04B |
Tax refund paid | -15.15B | -36.13%-31.48B | 7.97%-23.13B | -142.23%-25.13B | 37.44%-10.37B | -35.25%-16.58B | 66.29%-12.26B | -246.47%-36.37B | -30.77%-10.5B | -9.17%-8.03B |
Other operating cash inflow (outflow) | -1M | 0.00%-1M | -1M | 0 | 0 | 0 | 0 | -1M | 0 | 0 |
Operating cash flow | --66.24B | -26.95%84.86B | 51.24%116.16B | 185.21%76.81B | -41.56%26.93B | -16.13%46.09B | 3.39%54.95B | -8.66%53.15B | 20.09%58.19B | -5.85%48.45B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | ---25.96B | -12.67%-65.78B | -99.36%-58.38B | -46.75%-29.29B | 9.12%-19.96B | -40.96%-21.96B | -33.84%-15.58B | 34.34%-11.64B | -11.85%-17.73B | -10.22%-15.85B |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---9.42B | ---- | ---- | ---130M | ---- |
Net investment product transactions | --229M | -35.86%11.31B | 13.75%17.63B | -68.50%15.5B | 491.51%49.2B | 765.56%8.32B | 153.56%961M | -98.80%379M | 2,496.40%31.7B | 130.37%1.22B |
Advance cash and loans provided to other parties | ---2.79B | -29.67%-18.31B | -26.71%-14.12B | -226.10%-11.15B | 56.32%-3.42B | -6.02%-7.83B | -59.28%-7.38B | -6.02%-4.63B | 36.54%-4.37B | -5.48%-6.89B |
Repayment of advance payments to other parties and cash income from loans | --3.05B | 52.81%17.28B | 54.37%11.31B | 161.38%7.32B | -63.93%2.8B | 5.85%7.77B | 38.50%7.34B | 6.88%5.3B | -20.57%4.96B | 11.90%6.24B |
Net changes in other investments | ---1.58B | -16.58%-6.91B | -25.03%-5.93B | 7.98%-4.74B | -14.46%-5.15B | 33.69%-4.5B | -71.66%-6.79B | 15.56%-3.96B | -13.25%-4.68B | -21.72%-4.14B |
Investing cash flow | ---27.05B | -26.10%-62.42B | -121.47%-49.5B | -195.20%-22.35B | 185.00%23.48B | -28.78%-27.62B | -47.41%-21.45B | -249.26%-14.55B | 150.22%9.75B | 14.68%-19.41B |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---23.3B | 100.38%138M | -354.32%-36.33B | 12.78%-8B | -120.53%-9.17B | 481.64%44.67B | 49.27%-11.7B | 30.00%-23.07B | -273.17%-32.96B | 29.53%-8.83B |
Net common stock issuance | ---3M | -160.00%-26M | 47.37%-10M | -58.33%-19M | -20.00%-12M | 66.67%-10M | 30.23%-30M | -53.57%-43M | -3.70%-28M | 25.00%-27M |
Increase or decrease of lease financing | ---5.65B | -13.15%-24.47B | -5.23%-21.63B | -14.93%-20.55B | -22.27%-17.88B | -11.59%-14.63B | -2.51%-13.11B | 0.73%-12.79B | 11.12%-12.88B | 0.49%-14.49B |
Cash dividends paid | ---10.71B | -9.09%-17.14B | -22.22%-15.71B | -12.50%-12.86B | 0.00%-11.43B | 0.01%-11.43B | -33.33%-11.43B | -19.99%-8.57B | 0.01%-7.14B | -25.00%-7.14B |
Cash dividends for minorities | ---3.54B | -24.57%-4.37B | -168.20%-3.51B | -15.34%-1.31B | 21.36%-1.13B | -7.61%-1.44B | 43.32%-1.34B | -162.38%-2.36B | 10.08%-901M | -2.04%-1B |
Net other fund-raising expenses | ---- | 71.43%-2M | 95.73%-7M | -257.69%-164M | 142.28%104M | 56.54%-246M | -929.09%-566M | 97.47%-55M | -2,923.61%-2.18B | -7,100.00%-72M |
Financing cash flow | ---43.21B | 40.58%-45.87B | -79.96%-77.19B | -8.54%-42.89B | -333.61%-39.52B | 144.32%16.92B | 18.58%-38.17B | 16.40%-46.89B | -77.67%-56.08B | 6.69%-31.57B |
Net cash flow | ||||||||||
Beginning cash position | --65.54B | -7.87%84.17B | 21.26%91.35B | 18.18%75.33B | 118.80%63.75B | -12.59%29.13B | -20.43%33.33B | 35.83%41.89B | -3.31%30.84B | -4.54%31.9B |
Current changes in cash | ---4.01B | -122.52%-23.43B | -191.03%-10.53B | 6.22%11.57B | -69.23%10.89B | 857.18%35.38B | 43.64%-4.67B | -169.97%-8.29B | 569.12%11.85B | 50.65%-2.53B |
Effect of exchange rate changes | --2.54B | 49.72%4.81B | -27.91%3.21B | 554.85%4.45B | 188.08%680M | -328.40%-772M | 190.37%338M | 58.90%-374M | 56.65%-910M | -222.18%-2.1B |
Cash adjustments other than cash changes | --1.21B | -100.75%-1M | --133M | ---- | 1,700.00%18M | -99.29%1M | 29.63%140M | 0.00%108M | -96.97%108M | 89.38%3.57B |
End cash Position | --65.28B | -22.13%65.54B | -7.87%84.17B | 21.26%91.35B | 18.18%75.33B | 118.80%63.75B | -12.59%29.13B | -20.43%33.33B | 35.83%41.89B | -3.31%30.84B |
Free cash flow | --40.18B | -67.51%17.9B | 25.87%55.08B | 588.84%43.76B | -72.84%6.35B | -40.06%23.39B | -4.53%39.02B | 1.91%40.87B | 31.02%40.1B | -15.48%30.61B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |